Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 692 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pasithea Therapeutics Corp.
Market Cap
$15.15M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$15.01M
Net Profit Margin
-153.28%
TTM Avg
-93.42%
3Y Avg
-97.51%
5Y Avg
-105.13%
Market Cap
$15.58M
Net Profit Margin
-3011.52%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-79.84%
Market Cap
$15.83M
Net Profit Margin
-3575.07%
TTM Avg
-1754.85%
3Y Avg
-877.42%
5Y Avg
-584.95%
Market Cap
$14.29M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.15M
Net Profit Margin
-651.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$16.19M
Net Profit Margin
0.00%
TTM Avg
-6850.00%
3Y Avg
-4251.62%
5Y Avg
-4766.26%
Market Cap
$14.09M
Net Profit Margin
-39.61%
TTM Avg
-209.93%
3Y Avg
-392.71%
5Y Avg
-532.46%
Market Cap
$13.97M
Net Profit Margin
-8716.77%
TTM Avg
-1649.40%
3Y Avg
-960.30%
5Y Avg
-749.49%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $15.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.01M | -153.28% | -93.42% | -97.51% | -105.13% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | -3011.52% | 0.00% | 0.00% | -79.84% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | -3575.07% | -1754.85% | -877.42% | -584.95% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.29M | N/A | N/A | N/A | N/A |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.15M | -651.27% | 0.00% | 0.00% | 0.00% |
| BioCardia, Inc. (BCDA)vs › | $16.19M | 0.00% | -6850.00% | -4251.62% | -4766.26% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.09M | -39.61% | -209.93% | -392.71% | -532.46% |
| Vyome Holdings, Inc. (HIND)vs › | $13.97M | -8716.77% | -1649.40% | -960.30% | -749.49% |
| Dyadic International, Inc. (DYAI)vs › | $16.58M | -219.50% | -381.91% | -332.62% | -409.39% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 4183.66% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
